ARCHIVES

Small Phase II Study Finds New Oral Agent May Slow Progression Of Difficult Cancer

This article is from The Cancer Letter archive.

Vol. 32 No. 4 | April 24, 2009

Download PDF Visit The Full Archive

Related Articles

Consolidation Unlikely to Save Money

December 17, 2010

Cancer Policy; Cost Containment Impedes Research, Cancer Panel Finds

October 17, 1997

President’s Cancer Panel Road Show Producers Ideas For Improving Finding Mechanisms; NCI Buys Some

July 23, 1982

NCI advisors complete terms on board, Appelbaum’s term as BSA chairman ends.

July 23, 2004

SEC Investigating Bristol-Myers’ Sales Statements

July 12, 2002

Coalition Gives “Incomplete” To NCI, CDC Statistics, But Gets Low Grade From Critics

March 20, 1998